Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coya Therapeutics (COYA) Operating Expenses (2023 - 2025)

Historic Operating Expenses for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to $6.0 million.

  • Coya Therapeutics' Operating Expenses rose 3475.87% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.6 million, marking a year-over-year increase of 1761.84%. This contributed to the annual value of $20.8 million for FY2024, which is 4960.76% up from last year.
  • Coya Therapeutics' Operating Expenses amounted to $6.0 million in Q3 2025, which was up 3475.87% from $6.6 million recorded in Q2 2025.
  • In the past 5 years, Coya Therapeutics' Operating Expenses registered a high of $7.9 million during Q1 2025, and its lowest value of $2.9 million during Q1 2023.
  • Its 3-year average for Operating Expenses is $5.0 million, with a median of $4.5 million in 2024.
  • Within the past 5 years, the most significant YoY rise in Coya Therapeutics' Operating Expenses was 10469.24% (2024), while the steepest drop was 250.31% (2024).
  • Over the past 3 years, Coya Therapeutics' Operating Expenses (Quarter) stood at $4.2 million in 2023, then dropped by 2.5% to $4.1 million in 2024, then skyrocketed by 46.91% to $6.0 million in 2025.
  • Its Operating Expenses stands at $6.0 million for Q3 2025, versus $6.6 million for Q2 2025 and $7.9 million for Q1 2025.